Avant Brands Inc. cultivates and markets premium cannabis products in Canada. Key strengths include a solid gross margin of 33.5% and a healthy current ratio of 1.56, indicating good liquidity. However, concerns arise from low net margin (2.7%) and minimal returns on equity (0.9%), suggesting profitability challenges. Despite decent margins, the low market cap of $8.30M raises questions about valuation and growth potential in a competitive industry. Overall, while the company shows promise, it faces significant hurdles in achieving sustainable profitability.
Loading financial metrics...
Revenue fell 15.9% year-over-year from $37.5M to $31.5M. The decline has persisted for multiple quarters.
Company posted a loss of $-9.7M over the last year, representing 30.8% of revenue.
Debt of $12.1M is 10.9x the company's cash position of $1.1M.
Gross margin expanded by 19.9 percentage points, indicating improved pricing power or cost efficiency.
Operating margin expanded by 12.7pp, demonstrating strong operational leverage.
Both gross margin (+19.9pp) and operating margin (+12.7pp) are expanding simultaneously, indicating the company is scaling profitably.
Operating cash flow surged 95.2% YoY, indicating strong cash generation capability.
Strong cash flow conversion with 15.1% of revenue converting to operating cash.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q3 (August 31, 2026)